| 000 | 01696 a2200457 4500 | ||
|---|---|---|---|
| 005 | 20250516182712.0 | ||
| 264 | 0 | _c20150207 | |
| 008 | 201502s 0 0 eng d | ||
| 022 | _a1876-4479 | ||
| 024 | 7 |
_a10.1016/j.crohns.2013.10.013 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aAfzali, Anita | |
| 245 | 0 | 0 |
_aThe association of psoriasiform rash with anti-tumor necrosis factor (anti-TNF) therapy in inflammatory bowel disease: a single academic center case series. _h[electronic resource] |
| 260 |
_bJournal of Crohn's & colitis _cJun 2014 |
||
| 300 |
_a480-8 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAdalimumab |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aAntibodies, Monoclonal _xadverse effects |
| 650 | 0 | 4 |
_aAntibodies, Monoclonal, Humanized _xadverse effects |
| 650 | 0 | 4 | _aCertolizumab Pegol |
| 650 | 0 | 4 |
_aColitis, Ulcerative _xdrug therapy |
| 650 | 0 | 4 |
_aCrohn Disease _xdrug therapy |
| 650 | 0 | 4 |
_aExanthema _xchemically induced |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aImmunoglobulin Fab Fragments _xadverse effects |
| 650 | 0 | 4 |
_aInflammatory Bowel Diseases _xdrug therapy |
| 650 | 0 | 4 | _aInfliximab |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aPolyethylene Glycols _xadverse effects |
| 650 | 0 | 4 |
_aPsoriasis _xchemically induced |
| 650 | 0 | 4 | _aRetrospective Studies |
| 650 | 0 | 4 |
_aTumor Necrosis Factor-alpha _xantagonists & inhibitors |
| 700 | 1 | _aWheat, Chelle L | |
| 700 | 1 | _aHu, Jie Kate | |
| 700 | 1 | _aOlerud, John E | |
| 700 | 1 | _aLee, Scott D | |
| 773 | 0 |
_tJournal of Crohn's & colitis _gvol. 8 _gno. 6 _gp. 480-8 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.crohns.2013.10.013 _zAvailable from publisher's website |
| 999 |
_c23300960 _d23300960 |
||